ESR1 and neoplasm: Furthermore, the expression of three ERGs (TFF1, GREB1 and PR) was not decreased in treated tumours of a PDX highly responder to volasertib, indicating that PLK1 inhibition and response to volasertib are not associated with an impaired ER-dependent transcription.